Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved controlled release study of lomustine.

Y Sun1, H Zhou, Q Zhang

  • 1Department of Biomaterials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences, Tianjin, P.R.China.

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology
|March 23, 2000
PubMed
Summary

Researchers developed a novel method for preparing lomustine (CCNU) microcapsule membranes for sustained drug release. This innovative approach ensures a slow, constant delivery of CCNU, approximating zero-order release kinetics for potential therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disturbed expression of Fas/FasL on CD4(+) and CD8(+)T cells in Behcet's disease, Vogt-Koyanagi-Harada syndrome, and idiopathic anterior uveitis.

Ocular immunology and inflammation·2002
Same author

Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat.

American journal of physiology. Gastrointestinal and liver physiology·2002
Same author

[Expression and purification of murine interleukin 18 in Escherichia coli and its antitumor effects].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology·2002
Same author

[The value of nuclide myocardial scintigraphy for the clinical of acute viral myocarditis].

Zhonghua nei ke za zhi·2002
Same author

[The effects of Xuezhikang on serum lipid profile, thromboxane A2 and prostacyclin in patients with hyperlipidemia].

Zhonghua nei ke za zhi·2002
Same author

The distribution and significance of renal infiltrating cells in patients with diffuse crescentic glomerulonephritis.

Chinese medical journal·2002

Area of Science:

  • Biomaterials Science
  • Pharmaceutical Technology
  • Oncology Drug Delivery

Background:

  • Lomustine (CCNU) is a crucial chemotherapeutic agent.
  • Effective drug delivery systems are needed to optimize CCNU's therapeutic index and minimize side effects.
  • Controlled-release formulations can improve patient compliance and treatment efficacy.

Purpose of the Study:

  • To develop and characterize lomustine (CCNU) microcapsules embedded within a collagen-based membrane for sustained drug release.
  • To evaluate the release kinetics of CCNU from the prepared membrane formulation.
  • To assess the feasibility of using this formulation for in-body implantation and slow drug delivery.

Main Methods:

  • Improved recoacervation method used for CCNU microcapsule preparation.

Related Experiment Videos

  • Microcapsules were incorporated into a 0.7% collagen swelling solution to form an emulsion.
  • Emulsion was spread into a membrane, cross-linked, and prepared for implantation.
  • Ultraviolet spectrophotometry employed to quantify CCNU concentration and monitor release over time.

    • Main Results:

    • The prepared lomustine (CCNU) microcapsule membranes demonstrated a slow and constant release of the drug.
    • The release profile closely approximated zero-order kinetics, indicating predictable and sustained drug delivery.
    • Successful preparation of a membrane suitable for potential in-body implantation.

    Conclusions:

    • The developed lomustine (CCNU) microcapsule-collagen membrane system offers a promising approach for sustained and controlled drug delivery.
    • The observed zero-order release kinetics suggest potential for improved therapeutic outcomes and reduced dosing frequency.
    • This formulation represents a viable strategy for localized and prolonged chemotherapy delivery.